FDA Inspection
CTX Lifesciences Private Ltd.CTX Lifesciences Private Ltd. – FDA Inspection, Sep 2, 2022
Record Details
This FDA Inspection record concerns CTX Lifesciences Private Ltd., with an inspection on September 2, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- September 2, 2022
- Product Type
- Drugs
View Company Profile
ID · 9547f0c5-2bdd-41b6-bb03-049d4ea209d1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1182106
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of CTX Lifesciences Private Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 16, 2019 | Not classified | Office of Inspections and Investigations | |
| January 30, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 19, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 30, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for CTX Lifesciences Private Ltd.
- FDA Inspection 1081201 - 2019-02-16
- FDA Inspection 1041826 - 2018-01-30
- FDA Inspection 959937 - 2016-02-19
- FDA Inspection 813786 - 2012-12-30
- FDA Inspection 632058 - 2009-11-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.